Pharmacy World and Science

Quantification of communication processes, is it possible?
pp. 195-199(5)
Authors: IJben G.; van Mil J.W.F.; Tromp T.F.J.; de Jong-van den Berg L.T.W.

Patient education to users of oral hypoglycemic agents: the perspective of Dutch community pharmacists
pp. 200-204(5)
Authors: Timmer J.W.; de Smet P.A.G.M.; Schuling J.; Tromp T.F.J.; de Jong-van den Berg L.T.W.

APOM-project: managing change to the customer in community pharmacy practice
pp. 205-209(5)
Authors: Mobach M.P.; van der Werf J.J.; Tromp T..F.J.

A self-reported work sampling study in community pharmacy practice
pp. 210-216(7)
Authors: Bell H.M.; McElnay J.C.; Hughes C.M.

Agreement between self-reported antihypertensive drug use and pharmacy records in a population-based study in The Netherlands
pp. 217-220(4)
Authors: Klungel O.H.; de Boer A.; Paes A.H.P.; Herings R.M.C.; Seidell J.C.; Bakker A.

Quality assessment of drug sales data: the case of antibacterials in Iceland
pp. 221-226(6)
Authors: Björnsdóttir I.; Holme Hansen E.; Grímsson A.

Relationship between pharmacokinetic parameters of gentamicin and patient characteristics and/or clinical data in patients with solid organ tumours
pp. 227-232(6)
Authors: Ortega A.; Aldaz A.; Giráldez J.; Brugarolas A.

The relative bioavailability of metoprolol following oral and rectal administration to volunteers and patients
pp. 233-238(6)
Authors: de Stoppelaar F.M.; Stolk L.M.L.; Beysens A.J.; Stappers J.L.M.; Gorgels A.M.

Pilot study in humans on the pharmacokinetics and safety of propofol 6% SAZN
pp. 239-240(2)
Authors: Knibbe C.A.J.; Koster V.S.; Aarts L.P.H.J.; Langemeijer H.J.M.; Danhof M.

Acute eosinophilic pneumonia associated with antidepressant agents
pp. 241-242(2)
Authors: Barnés M.T.; Bascuñana J.; García B.; L. Alvarez-Sala J.

Elevated plasma levels of clozapine after concomitant use of fluvoxamine
pp. 243-244(2)
Authors: Heeringa M.; Beurskens R.; Schouten W.; Verduijn M.M.